Lung cancer remains one of the leading causes of cancer-related death worldwide, partly due to late diagnosis, drug resistance, and side effects from traditional treatments. This review explores how phytocannabinoids—natural compounds like cannabidiol (CBD) and cannabigerol (CBG)—may be combined with nanotechnology to improve cancer treatment. Researchers focused on a specific type of nanocarrier called halloysite […]
Category: Cancer
Hemp Oils and Cancer Research: The Emerging Role of Antioxidants in Prevention and Supportive Care (pub. June 2025)
Cancer development is closely linked to oxidative stress, a process where harmful molecules called free radicals damage cells and DNA over time. This scientific review examines how hemp oils, derived from Cannabis sativa, may help counter these effects due to their rich content of natural antioxidants, including cannabinoids, flavonoids, and terpenes. Researchers analyzed existing laboratory […]
Cannabichromene (CBC), Cannabigerol (CBG), and Related Compounds Show Early Antitumor Activity Against Glioma (pub. June 2025)
Gliomas are aggressive brain tumors with poor prognosis, and new therapeutic strategies are urgently needed. This study used a combined in silico (computer modeling) and in vitro (laboratory cell) approach to evaluate whether compounds from Cannabis sativa—including cannabichromene (CBC) and cannabigerol (CBG)—as well as related natural molecules, may inhibit the growth of malignant glioma cells. […]